<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02001831</url>
  </required_header>
  <id_info>
    <org_study_id>SMF-3000</org_study_id>
    <nct_id>NCT02001831</nct_id>
  </id_info>
  <brief_title>Multi-ingredient Nutrition Supplement in Older Adults</brief_title>
  <official_title>Effect of a Nutrition Supplement Containing Fish Oil, Whey Protein, Vitamin D, and Resveratrol, on Muscular and Cognitive Function in Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College Dublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Smartfish AS</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University College Dublin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of the present study are:&#xD;
&#xD;
      i. To conduct a population study of body composition, muscle function and ability to&#xD;
      undertake activities of daily living in elderly Irish individuals&#xD;
&#xD;
      ii. To investigate the effect of a six month period of nutrition supplement support on lean&#xD;
      tissue mass, and muscle and cognitive function in individuals aged 70 to 80 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a population study and 6 month randomised control trial (RCT) of men and women&#xD;
      aged 70 to 80. The supplement and placebo will be provided in the form of a small 200 mL&#xD;
      sealed TetraPak carton and is presented in a highly-palatable, juice-based (pomegranate and&#xD;
      apple) formulation. The study groups (n=25 per group) for the RCT are:&#xD;
&#xD;
      Control - a control group receiving a placebo nutrient support (200 mL juice; energy ~ 100&#xD;
      kcal per day)&#xD;
&#xD;
      Supplement - a nutrient group receiving a liquid nutrient support (quantity 200 mL per day;&#xD;
      energy 200 kcal per day):&#xD;
&#xD;
      Carbohydrate 28.5 g Protein 8 g as Whey Protein Isolate (i) ω-3 PUFA (ii) 3000 mg, as DHA&#xD;
      1500mg, as EPA 1500mg Vitamin D3 (iii) 10 μg Resveratrol (iv) 150 mg&#xD;
&#xD;
      (i) Whey protein isolate - increasing protein intake in elderly individuals is widely&#xD;
      proposed as key preventing the decline in muscle mass with aging, (ii) ω-3/EPA/DHA fatty&#xD;
      acids - increasing ω-3 consumption is associated with improvements in inflammatory status,&#xD;
      blood lipid profile and cognitive function in various populations (iii) A relative deficiency&#xD;
      in vitamin D is widely reported in Western populations, whereas recent reports have suggested&#xD;
      vitamin D3 supplementation as efficacious for muscle function, (iv) Resveratrol, a polyphenol&#xD;
      derived from grape skin that shows promise as a supplement to improve muscle function,&#xD;
      metabolic health, prevent wasting and promote longevity.&#xD;
&#xD;
      Participants will undertake a first preliminary screening, which will take part at the Human&#xD;
      Performance Laboratory at the University College Dublin (UCD) Institute for Sport and Health,&#xD;
      or, alternatively, in a home-based environment, according to participants preferences, in&#xD;
      order to assess inclusion/exclusion criteria.&#xD;
&#xD;
      After having examined the participant information leaflet, participants will provide informed&#xD;
      consent in writing, complete the medical history examination, a food intake diary and food&#xD;
      frequency questionnaire as well as habitual physical activity level questionnaire (CHAMPS).&#xD;
&#xD;
      Next, they will have their stature, body composition, and functional capacity assessed as&#xD;
      described below. If fulfilling the eligibility criteria, subjects will undertake 3 assessment&#xD;
      sessions (at baseline, 12 wk &amp; 24 wk) at the Human Performance Laboratory at the UCD&#xD;
      Institute for Sport and Health, consisting of body composition, functional capacity, and&#xD;
      cognitive performance assessment.&#xD;
&#xD;
      In detail:&#xD;
&#xD;
      i. Body composition (fat, muscle and bone mass by Dual Energy X-Ray Absorptiometry (DXA)&#xD;
      (Expected time ~ 15 min)&#xD;
&#xD;
      ii. Provide a blood sample taken via venepuncture to a superficial antecubital vein to be&#xD;
      later analysed to assess lipidemic profile, plasma glucose, insulin, and inflammatory markers&#xD;
      (Expected time ~ 5 min)&#xD;
&#xD;
      iii. Measurement of muscle strength and lower extremity muscle function in simulated&#xD;
      activities of daily living by hand grip, usual walking speed, chair rise test, sit and reach&#xD;
      test, and balance test [Short Performance Battery Test (Guralnik et al. 1994)]. (Expected&#xD;
      time ~ 40 min)&#xD;
&#xD;
      iv. Assessment of cognitive function by the following battery modeled upon that used in Witte&#xD;
      et al. (2013) (Expected time ~ 45 min):&#xD;
&#xD;
        -  Timed Up and Go test&#xD;
&#xD;
        -  Trail Making Test (TMT) part A and B&#xD;
&#xD;
        -  Auditory Verbal Learning Test&#xD;
&#xD;
        -  Stroop Colour-Word Test&#xD;
&#xD;
        -  Verbal Fluency&#xD;
&#xD;
        -  Forward and Backward Digit Spans&#xD;
&#xD;
        -  Cognitive Failures Questionnaire&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total and appendicular muscle mass</measure>
    <time_frame>Change from Baseline at day 84 &amp; day 168</time_frame>
    <description>By means of measurement of lean body mass using dual-energy X-ray absorptiometry (DXA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lower extremity physical function</measure>
    <time_frame>Change from Baseline at day 84 &amp; day 168</time_frame>
    <description>By means of score ranging from 0 (worst performance) to 12 (best performance) achieved on the Short Performance Battery Test (Guralnik et al J Gerontol. 1994 49(2):M85-94)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive performance</measure>
    <time_frame>Change from Baseline at day 84 &amp; day 168</time_frame>
    <description>By means of performances in the following battery: Timed Up and Go test, Trail Making Test (TMT) part A and B, Auditory Verbal Learning Test, Stroop Colour-Word Test, Verbal Fluency, Forward and Backward Digit Spans, and Cognitive Failures Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Physical Disability</condition>
  <arm_group>
    <arm_group_label>Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Liquid nutrient support (quantity 200 mL per day; energy 200 kcal per day):&#xD;
Carbohydrate 28.5 g&#xD;
Protein 8 g as Whey Protein Isolate&#xD;
ω-3 PUFA 3000 mg, as DHA 1500mg, as EPA 1500mg&#xD;
Vitamin D3 10 μg&#xD;
Resveratrol 150 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo control&#xD;
Liquid nutrient support&#xD;
Quantity 200 mL per day - fruit juice only i,e. in absence of bioactives present in the &quot;supplement&quot; (whey protein, omega 3, vitamin D and resveratrol).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Supplement</intervention_name>
    <arm_group_label>Supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 70 years of age&#xD;
&#xD;
          -  Medically stable, according to Greig et al. (1994)&#xD;
&#xD;
          -  BMI between 20 and 30 kg/m2&#xD;
&#xD;
          -  Sedentary lifestyle, defined by ≤125 min/week of activity on the CHAMPS-18&#xD;
             questionnaire;&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Not medically stable by Greig criteria, and the medical history details in the ethics&#xD;
             form&#xD;
&#xD;
          -  Conducting an active lifestyle&#xD;
&#xD;
          -  Skeletal muscle index (SMI) of ≥ 6.75 kg/m2 for women or ≥ 10.75 kg/m2 for men&#xD;
             according to Janssen et al. (2003)&#xD;
&#xD;
          -  Cognitive impairment expressed as mini mental state examination (MMSE) score ≤ 23.&#xD;
&#xD;
          -  Current or recent (8 wk) use of fish-oil supplement intake&#xD;
&#xD;
          -  Current or recent (8 wk) use of proteins, vitamins or other supplements interfering&#xD;
             the metabolic scope&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giuseppe De Vito, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>School of Public Health, Physiotherapy and Population Sciences. University College Dublin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brendan Egan, PhD</last_name>
    <email>brendan.egan@ucd.ie</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCD Institute for Sport and Health</name>
      <address>
        <city>Dublin</city>
        <zip>Dublin 4</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <reference>
    <citation>Greig CA, Young A, Skelton DA, Pippet E, Butler FM, Mahmud SM. Exercise studies with elderly volunteers. Age Ageing. 1994 May;23(3):185-9.</citation>
    <PMID>8085501</PMID>
  </reference>
  <reference>
    <citation>Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004 Feb 15;159(4):413-21.</citation>
    <PMID>14769646</PMID>
  </reference>
  <reference>
    <citation>Witte AV, Kerti L, Hermannstädter HM, Fiebach JB, Schreiber SJ, Schuchardt JP, Hahn A, Flöel A. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex. 2014 Nov;24(11):3059-68. doi: 10.1093/cercor/bht163. Epub 2013 Jun 24.</citation>
    <PMID>23796946</PMID>
  </reference>
  <reference>
    <citation>Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 Mar;49(2):M85-94.</citation>
    <PMID>8126356</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>August 15, 2013</study_first_submitted>
  <study_first_submitted_qc>November 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2013</study_first_posted>
  <last_update_submitted>November 28, 2013</last_update_submitted>
  <last_update_submitted_qc>November 28, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University College Dublin</investigator_affiliation>
    <investigator_full_name>Brendan Egan</investigator_full_name>
    <investigator_title>Lecturer in Sport and Exercise Science</investigator_title>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>Frailty</keyword>
  <keyword>Aging</keyword>
  <keyword>Skeletal muscle</keyword>
  <keyword>Nutrition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

